 |
pembrolizumab |
|---|---|
| Trade Name | Keytruda |
| Orphan Indication | Esophageal carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Merck, Sharp & Dohme, subsidiary of Merck & Co., Inc.;1 Merck Drive;Whitehouse Station, New Jersey, 08889 |
